Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × gallium 68 PSMA-11 × Clear all

Phase

Phase NA 2 Phase EARLY_PHASE1 2 Phase 2 1 Phase 1/2 1

Status

Completed 13 Recruiting 8 Active not recruiting 6 Terminated 5 Withdrawn 4 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cisplatin 265 Oxaliplatin 192 Carboplatin 189 Capecitabine 182 Docetaxel 174 apatinib 165 Paclitaxel 158 Bevacizumab 153 Gemcitabine 149 Radiotherapy 146 camrelizumab 145 Fluorouracil 143 Cyclophosphamide 125 Irinotecan 119 Drug Therapy 113 sintilimab 106 Etoposide 99 anlotinib 90 S 1 (combination) 88 Leucovorin 83 pembrolizumab 80 Doxorubicin 79 Pemetrexed 76 toripalimab 74 tislelizumab 73 Dexamethasone 69 Rituximab 64 Trastuzumab 63 Neoadjuvant Therapy 63 Cetuximab 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02282137 2020-08-19

PSMA

Radio Isotope Therapy of America

Phase 2 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡